Eco-Friendly ingenuities are motivating huge growth in the industry of plant-based plastic packaging market. The industry is chiefly driven by eco-friendly characteristics of these plastic. North America is foretold to be the utmost reve…
BMI View: The Hungarian government's fiscal stimulus initiatives will boost the private consumption of
pharmaceuticals, particularly the over the counter medicines segment. A secondary set of initiatives are
aimed at increasing domestic production capabilities, such as the pharmaceutical sector. While this will
increase competition in the slow-growth domestic medicine market, it may lead to increased incentives for
manufacturers to locate manufacturing facilities in the country as a regional hub.
Headline Expenditure Projections
? Pharmaceuticals: HUF660.8bn (USD2.4bn) in 2015 to HUF667.6bn (USD2.3bn) in 2016; +1.0% in
local currency terms and -1.2% in US dollar terms. Forecast unchanged from last quarter.
? Healthcare: HUF2.5trn (USD9.0bn) in 2015 to HUF2.6trn (USD9.1bn) in 2016; +5.0% in local currency
terms and 2.7% in US dollar terms. Forecast unchanged from last quarter.
While Hungary's Risks score profile is generally predictable, Hungary's Rewards score has improved
considerably due to favourable currency effects and our improving outlook for the country's pharmaceutical